These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17786022)

  • 1. Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington's disease models and enhance killing of mycobacteria by macrophages.
    Floto RA; Sarkar S; Perlstein EO; Kampmann B; Schreiber SL; Rubinsztein DC
    Autophagy; 2007; 3(6):620-2. PubMed ID: 17786022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecules enhance autophagy and reduce toxicity in Huntington's disease models.
    Sarkar S; Perlstein EO; Imarisio S; Pineau S; Cordenier A; Maglathlin RL; Webster JA; Lewis TA; O'Kane CJ; Schreiber SL; Rubinsztein DC
    Nat Chem Biol; 2007 Jun; 3(6):331-8. PubMed ID: 17486044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin.
    Sarkar S; Krishna G; Imarisio S; Saiki S; O'Kane CJ; Rubinsztein DC
    Hum Mol Genet; 2008 Jan; 17(2):170-8. PubMed ID: 17921520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies.
    Sarkar S; Ravikumar B; Floto RA; Rubinsztein DC
    Cell Death Differ; 2009 Jan; 16(1):46-56. PubMed ID: 18636076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin alleviates toxicity of different aggregate-prone proteins.
    Berger Z; Ravikumar B; Menzies FM; Oroz LG; Underwood BR; Pangalos MN; Schmitt I; Wullner U; Evert BO; O'Kane CJ; Rubinsztein DC
    Hum Mol Genet; 2006 Feb; 15(3):433-42. PubMed ID: 16368705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin pre-treatment protects against apoptosis.
    Ravikumar B; Berger Z; Vacher C; O'Kane CJ; Rubinsztein DC
    Hum Mol Genet; 2006 Apr; 15(7):1209-16. PubMed ID: 16497721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian target of Rapamycin inhibition and mycobacterial survival are uncoupled in murine macrophages.
    Zullo AJ; Jurcic Smith KL; Lee S
    BMC Biochem; 2014 Feb; 15():4. PubMed ID: 24528777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huntington's disease: degradation of mutant huntingtin by autophagy.
    Sarkar S; Rubinsztein DC
    FEBS J; 2008 Sep; 275(17):4263-70. PubMed ID: 18637946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.
    Ravikumar B; Vacher C; Berger Z; Davies JE; Luo S; Oroz LG; Scaravilli F; Easton DF; Duden R; O'Kane CJ; Rubinsztein DC
    Nat Genet; 2004 Jun; 36(6):585-95. PubMed ID: 15146184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin inhibits polyglutamine aggregation independently of autophagy by reducing protein synthesis.
    King MA; Hands S; Hafiz F; Mizushima N; Tolkovsky AM; Wyttenbach A
    Mol Pharmacol; 2008 Apr; 73(4):1052-63. PubMed ID: 18199701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway.
    Williams A; Sarkar S; Cuddon P; Ttofi EK; Saiki S; Siddiqi FH; Jahreiss L; Fleming A; Pask D; Goldsmith P; O'Kane CJ; Floto RA; Rubinsztein DC
    Nat Chem Biol; 2008 May; 4(5):295-305. PubMed ID: 18391949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chips.
    Huang J; Zhu H; Haggarty SJ; Spring DR; Hwang H; Jin F; Snyder M; Schreiber SL
    Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16594-9. PubMed ID: 15539461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of autophagy in the clearance of mutant huntingtin: a step towards therapy?
    Ravikumar B; Rubinsztein DC
    Mol Aspects Med; 2006; 27(5-6):520-7. PubMed ID: 16973207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AUTEN-67 (Autophagy Enhancer-67) Hampers the Progression of Neurodegenerative Symptoms in a Drosophila model of Huntington's Disease.
    Billes V; Kovács T; Hotzi B; Manzéger A; Tagscherer K; Komlós M; Tarnóci A; Pádár Z; Erdős A; Bjelik A; Legradi A; Gulya K; Gulyás B; Vellai T
    J Huntingtons Dis; 2016 May; 5(2):133-47. PubMed ID: 27163946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy is required for extension of yeast chronological life span by rapamycin.
    Alvers AL; Wood MS; Hu D; Kaywell AC; Dunn WA; Aris JP
    Autophagy; 2009 Aug; 5(6):847-9. PubMed ID: 19458476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of autophagy with catalytic mTOR inhibitors reduces huntingtin aggregates in a neuronal cell model.
    Roscic A; Baldo B; Crochemore C; Marcellin D; Paganetti P
    J Neurochem; 2011 Oct; 119(2):398-407. PubMed ID: 21854390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conophylline protects cells in cellular models of neurodegenerative diseases by inducing mammalian target of rapamycin (mTOR)-independent autophagy.
    Sasazawa Y; Sato N; Umezawa K; Simizu S
    J Biol Chem; 2015 Mar; 290(10):6168-78. PubMed ID: 25596530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.
    Williams A; Jahreiss L; Sarkar S; Saiki S; Menzies FM; Ravikumar B; Rubinsztein DC
    Curr Top Dev Biol; 2006; 76():89-101. PubMed ID: 17118264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neferine attenuates the protein level and toxicity of mutant huntingtin in PC-12 cells via induction of autophagy.
    Wong VK; Wu AG; Wang JR; Liu L; Law BY
    Molecules; 2015 Feb; 20(3):3496-514. PubMed ID: 25699594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein.
    Sarkar S; Davies JE; Huang Z; Tunnacliffe A; Rubinsztein DC
    J Biol Chem; 2007 Feb; 282(8):5641-52. PubMed ID: 17182613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.